RADIATION THERAPY ONCOLOGY GROUP
RTOG 0623
A PHASE II TRIAL OF COMBINED MODALITY THERAPY WITH GROWTH FACTOR SUPPORT FOR PATIENTS WITH LIMITED STAGE SMALL CELL LUNG CANCER
RTOG 0623
A PHASE II TRIAL OF COMBINED MODALITY THERAPY WITH GROWTH FACTOR SUPPORT FOR PATIENTS WITH LIMITED STAGE SMALL CELL LUNG CANCER
Protocol Participation Information
- Credentialing
- Credentialing Requirements
- Facility Questionnaire: Part I and Part III are required for this protocol.
- How to Participate
- Digital Data Submission Procedures
- Digital Data Submission Information (DDSI) Form
- ATC Compliant Treatment Planning Systems
- Structure Names
- Protocol Text (http://www.rtog.org)
Back to protocols
